Therapy Areas: Vaccines
Sanofi to acquire Vicebio for USD1.15bn to strengthen respiratory vaccine pipeline
22 July 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Tuesday that it has entered into an agreement to acquire London-based biotechnology company Vicebio ...
Bavarian Nordic chikungunya vaccine enters Health Canada review process
22 July 2025 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Tuesday that Health Canada has accepted its New Drug Submission for CHIKV VLP, a single-dose chikungunya vacci...
SK bioscience submits IND for Phase 1/2 clinical trial of new influenza vaccine candidate
18 July 2025 - South Korea-based vaccine and biotech company SK bioscience announced on Thursday that it has submitted an Investigational New Drug (IND) application to the Ministry of Food and Drug Sa...
GC Biopharma secures Vietnamese approval for varicella vaccine BARYCELA
17 July 2025 - South Korean biopharmaceutical company GC Biopharma (KRX: 006280) announced on Thursday that it has received marketing authorisation from the Drug Administration of Vietnam for its vari...
GSK announces submission of RSV vaccine Arexvy for FDA review
14 July 2025 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that it has submitted an application to the US Food and Drug Administration (FDA) to expand the approved use...
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
10 July 2025 - Needle-free injection technology company PharmaJet said on Thursday that it has signed a Memorandum of Understanding with the Egyptian Unified Procurement Authority (UPA) and EVA Pharma...